O
MD icon

OrbiMed’s Pediatrix Medical MD Stock Holding History

OrbiMed’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,469,300
Closed -$68.6M – 146
2018
Q3 		$68.6M Buy
1,469,300
+606,700
+70% +$27.9M 0.83% 37
2018
Q2 		$37.3M Buy
862,600
+492,600
+133% +$23.6M 0.45% 60
2018
Q1 		$20.6M Buy
+370,000
New +$20.3M 0.26% 80

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed's MD Position: Q4 2018 in Review

OrbiMed sold out of Pediatrix Medical (MD) in Q4 2018, closing a stake of 1,469,300 shares — an estimated $68.6M sold.

OrbiMed first reported a position in MD in Q1 2018 and held it in 3 quarters. The position peaked at $68.6M in Q3 2018. 307 funds tracked by Wall St. Rank hold MD as of Q4 2018.

  • OrbiMed reported no remaining Pediatrix Medical position as of Q4 2018 after selling out during the quarter.
  • OrbiMed sold 1,469,300 Pediatrix Medical shares in Q4 2018, an estimated $68.6M.
  • OrbiMed first reported a position in Pediatrix Medical in Q1 2018 and held it in 3 quarters.
  • OrbiMed's Pediatrix Medical position peaked at $68.6M in Q3 2018.
  • 307 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.